Sensex
76,009.70 profit arw -479.26 (-0.63%)
Nifty
23,913.70 profit arw -118.00 (-0.49%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 27-Apr-2026
Corporate News
27-Apr-2026     09:06

Board of Cohance Lifesciences approves change in chairman

The board of Cohance Lifesciences at its meeting held on 27 April 2026 has approved the following:

Noted the resignation of Vivek Sharma (DIN 08559495), as Executive Chairman and director of the Company with effect from 30 April 2026.

Approved the appointment of Umang Vohra as Additional Director, designated as Chairman, and Group Chief Executive Officer with effect from 01 May 2026 and 20 May 2026 respectively.

INDIAN INDICES

Sensex

76,009.70 -479.26 (-0.63%)

Nifty

23,913.70 -118.00 (-0.49%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

25,599.46 -6.58(-0.03%)